全球中毒性表皮坏死松解症市场 – 行业趋势和 2030 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球中毒性表皮坏死松解症市场 – 行业趋势和 2030 年预测

  • Healthcare
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Toxic Epidermal Necrolysis Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2023 –2030
Diagram Market Size (Base Year)
USD 7.60 Billion
Diagram Market Size (Forecast Year)
USD 10.40 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Mönlycke Health Care AB
  • maxill
  • Cadila Pharmaceuticals
  • BD
  • Schulke India Pvt.

>全球中毒性表皮坏死松解症市场,按症状(发烧、身体疼痛、发红、刺痛、吞咽困难、流鼻涕、咳嗽、喉咙痛)、诊断(体检、病史、皮肤活检、血液检查、培养)、治疗(住院、药膏和绷带、静脉 (IV) 液体和电解质、隔离)划分 - 行业趋势和预测到 2030 年。

中毒性表皮坏死松解症市场

 中毒性表皮坏死松解症市场分析和规模

中毒性表皮坏死松解症 (TEN) 是一种罕见的、危及生命的药物性皮肤病,死亡率为 30%。TEN 的临床特征是大面积角质形成细胞死亡导致的显著皮肤脱落,并伴有粘膜受累。TEN 的确切致病机制尚不清楚。该领域的最新进展已确定了可能导致角质形成细胞凋亡的几种因素。此外,特定的人类白细胞抗原类型似乎与某些药物和 TEN 的发展有关。

Data Bridge Market Research 分析,中毒性表皮坏死松解症市场在 2022 年的规模为 76 亿美元,预计到 2030 年将达到 104 亿美元,在 2023 年至 2030 年的预测期内的复合年增长率为 4%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

中毒性表皮坏死松解症市场范围和细分  

报告指标

细节

预测期

2023 至 2030 年

基准年

2022

历史岁月

2021(可定制为 2015 - 2020)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

症状(发烧、身体疼痛、红肿、刺痛、吞咽困难、流鼻涕、咳嗽、喉咙痛)、诊断(体检、病史、皮肤活检、血液检查、培养)、治疗(住院、药膏和绷带、静脉(IV)输液和电解质、隔离)

覆盖国家

北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、巴西、阿根廷和南美洲的其他地区。

涵盖的市场参与者

Mölnlycke Health Care AB (Sweden), maxill inc. (Canada), Cadila Pharmaceuticals (India), BD (U.S.), Schulke India Pvt. Ltd. (India), Smith+Nephew (U.K.), Basic Pharma Life Science Pvt Ltd. (India), PSK Pharma Pvt.Ltd (India), Avrio Health L.P. (U.S.), 3M (U.S.), Biesterfeld AG (Germany), Vesimin Health (Spain) and  Mylan N.V. (Spain)

Market Opportunities

  • Rising healthcare infrastructure

Market Definition

Toxic epidermal necrolysis (TEN) is a rare and severe skin disease. It is sometimes caused by a negative drug reaction, such as anticonvulsants and antibiotics. The primary symptom is rapid peeling, which results in large, raw areas that can ooze or weep.

Global Toxic Epidermal Necrolysis Market Dynamics

Drivers

  • Usage of Toxic Epidermal Necrolysis

The primary treatment for TEN is supportive care until the affected skin has re-epithelialized. Fluid resuscitation, pain management, wound care, and nutritional support are examples of supportive measures. The emergency department should prioritise two things in these cases: discontinuation of the offending drug and early referral to a burn unit or intensive care unit with experience in dealing with such cases. These two measures, when taken within the first 24 hours of blister formation, reduce infection rates, hospital stays, and improve overall survival.

Opportunities

  • Usage of antibiotics

Antibiotics are expected to contribute significantly to growth in the toxic epidermal necrolysis market during the forecast period. Antibiotics are prescribed to the majority of patients suffering from toxic epidermal neurolysis in order to prevent or treat infections. On the other hand, immunoglobulins, are expected to contribute significantly to growth in the toxic epidermal necrolysis market during the forecast period.

Restraints/Challenges

The disorder can be caused by a drug reaction often antibiotics or anticonvulsive which may hamper the growth of the toxic epidermal necrolysis market in the above mentioned period.

This toxic epidermal necrolysis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the toxic epidermal necrolysis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Toxic Epidermal Necrolysis Market Scope

中毒性表皮坏死松解症市场根据症状、诊断和治疗进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

症状

  • 发烧
  • 身体疼痛
  • 红色的
  • 刺痛 是
  • 吞咽困难
  • 流鼻涕
  • 咳嗽
  • 咽喉痛

 诊断

  • 体格检查
  • 病史
  • 皮肤活检
  • 验血
  • 文化

 治疗

  • 住院
  • 药膏和绷带
  • 静脉输液 (IV) 和电解质
  • 隔离

中毒性表皮坏死松解症市场区域分析/见解

对中毒性表皮坏死松解症市场进行了分析,并按国家、症状、诊断和治疗提供了上述市场规模见解和趋势。

中毒性表皮坏死松解症市场报告涉及的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于患者认识的不断提高和人口的快速增长,北美在毒性表皮坏死松解症市场占据主导地位。

由于人们生活方式的改变和人均支出的增加,预计亚太地区将在 2023 年至 2030 年的预测期内以最高的增长率增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

中毒性表皮坏死松解症市场还为您提供了每个国家/地区资本设备医疗保健支出增长、中毒性表皮坏死松解症市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对中毒性表皮坏死松解症市场的影响的详细市场分析。数据适用于 2011-2021 年的历史时期。

竞争格局和中毒性表皮坏死松解症市场份额分析

中毒性表皮坏死松解症市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对中毒性表皮坏死松解症市场的关注有关。

中毒性表皮坏死松解症市场的一些主要参与者包括:

  • Mölnlycke Health Care AB(瑞典)
  • maxill inc.(加拿大)
  • 卡迪拉制药(印度)
  • BD(美国)
  • 舒尔克印度列兵。有限公司(印度)
  • Smith+Nephew(英国)
  • Basic Pharma Life Science Pvt Ltd.(印度)
  • PSK Pharma Pvt.Ltd(印度)
  • Avrio Health LP(美国)
  • 3M(美国)
  • Biesterfeld AG(德国)
  • Vesimin Health(西班牙)
  • Mylan NV (西班牙) 


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on , By Symptoms (Fever, Body Aches, Red, Stinging Yes, Difficulty Swallowing, Runny Nose, Coughing, Sore Throat), Diagnosis (Physical Exam, Medical History, Skin Biopsy, Blood Test, Cultures), Treatment (Hospitalization, Ointments and Bandages, Intravenous (IV) Fluid and Electrolytes, Isolation) – Industry Trends and Forecast to 2030. .
The Global Toxic Epidermal Necrolysis Market size was valued at USD 7.60 USD Billion in 2022.
The Global Toxic Epidermal Necrolysis Market is projected to grow at a CAGR of 4% during the forecast period of 2023 to 2030.
The major players operating in the market include Mönlycke Health Care AB, maxill , Cadila Pharmaceuticals, BD, Schulke India Pvt. , Smith+Nephew, Basic Pharma Life Science , PSK Pharma Pvt.Ltd, Avrio Health L.P., 3M, Biesterfeld AG, Vesimin Health, Mylan N.V..
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..